as of 12-05-2025 3:44pm EST
Adtalem Global Education Inc is an American for-profit educational company that operates various university and educational programs. The company has three segments namely Chamberlain; Walden; and Medical and Veterinary. It derives maximum revenue from Chamberlain segment.
| Founded: | 1987 | Country: | United States |
| Employees: | N/A | City: | CHICAGO |
| Market Cap: | 5.4B | IPO Year: | 1991 |
| Target Price: | $145.67 | AVG Volume (30 days): | 663.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 6.69 | EPS Growth: | 53.29 |
| 52 Week Low/High: | $84.79 - $156.26 | Next Earning Date: | 10-30-2025 |
| Revenue: | $1,833,178,000 | Revenue Growth: | 12.24% |
| Revenue Growth (this year): | 9.83% | Revenue Growth (next year): | 6.11% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Director
Avg Cost/Share
$98.29
Shares
508
Total Value
$49,931.32
Owned After
18,783
SEC Form 4
Director, Other
Avg Cost/Share
$91.85
Shares
1,000
Total Value
$91,850.00
Owned After
100,445
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Phelan Kenneth J | ATGE | Director | Nov 5, 2025 | Buy | $98.29 | 508 | $49,931.32 | 18,783 | |
| MALAFRONTE MICHAEL W | ATGE | Director, Other | Nov 4, 2025 | Buy | $91.85 | 1,000 | $91,850.00 | 100,445 |
See how ATGE stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "ATGE Adtalem Global Education Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.